Reply:
Zhiping Li – 27 February 2008
Isolation and characterization of a novel population of progenitor cells from unmanipulated rat liver
M. Behnan Sahin, Robert E. Schwartz, Shannon M. Buckley, Yves Heremans, Lucas Chase, Wei‐Shou Hu, Catherine M. Verfaillie – 27 February 2008 – Widespread use of liver transplantation in the treatment of hepatic diseases is restricted by the limited availability of donated organs. One potential solution to this problem would be isolation and propagation of liver progenitor cells or stem cells. Here, we report on the isolation of a novel progenitor cell population from unmanipulated (that is, no prior exposure to chemicals and no injury) adult rat liver.
Interfering with interferon: Re‐igniting the debate on calcineurin inhibitor choice and antiviral therapy for hepatitis C virus recurrence
Koichi Watashi, Herold J. Metselaar, Luc J. W. van der Laan – 27 February 2008
Rendezvous penetration method using double‐balloon endoscopy for complete anastomosis obstruction of hepaticojejunostomy after pediatric living donor liver transplantation
Youichi Kawano, Koichi Mizuta, Shuji Hishikawa, Satoshi Egami, Takehito Fujiwara, Masanobu Hyodo, Yoshikazu Yasuda, Tomonori Yano, Katsuyuki Nakazawa, Hironori Yamamoto, Hideo Kawarasaki – 27 February 2008
Preemptive treatment of fungal infection: has its time arrived in liver transplantation?
James D. Perkins – 27 February 2008
Reply:
M. Eric Gershwin – 27 February 2008
Erratum
27 February 2008
Treatment of portopulmonary hypertension—Isn't it time to move forward?
Karen L. Swanson – 27 February 2008
Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension
Mark J. Austin, Neil I. McDougall, Julia A. Wendon, Elizabeth Sizer, Alex S. Knisely, Mohammed Rela, Carol Wilson, Michael E. Callender, John G. O'Grady, Michael A. Heneghan – 27 February 2008 – Portopulmonary hypertension (PPHTN) represents a constrictive pulmonary vasculopathy in patients with portal hypertension. Liver transplantation (LT) may be curative and is usually restricted to patients with mild‐to‐moderate disease severity characterized by a mean pulmonary artery pressure (mPAP < 35 mm Hg).